Seer, Inc. 和韩国大学的研究旨在寻找新的血液生物标记,以便在青年中早期发现癌症。 Seer, Inc. and Korea University study aims to find new blood biomarkers for early cancer detection in young adults.

Seer, Inc.和韩国大学正在进行一项大规模研究,为青年成人确定新的基于血液的癌症生物标志。 Seer, Inc. and Korea University are conducting a large-scale study to identify new blood-based cancer biomarkers for young adults. 这个为期三年的项目将利用Seer的Protegraphic One Asssay和质量光谱测量等先进技术,分析癌症病人和健康个人的20,000个等离子体样本。 Using advanced technology like Seer's Proteograph ONE Assay and mass spectrometry, the three-year project will analyze 20,000 plasma samples from cancer patients and healthy individuals. 该研究由韩国政府资助,旨在开发用于早期癌症检测和改善年轻成年人结果的AI动力诊断方法。 Funded by the Korean government, the study aims to develop AI-powered diagnostics for earlier cancer detection and improved outcomes in young adults.